0.79% -0.010

Puma Biotechnology Inc (PBYI)

Puma Biotechnology Inc Borsa (PBYI) Ultime notizie

Puma Biotechnology Inc (PBYI)

Puma Biotechnology Inc Borsa (PBYI) Ultime notizie

Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment? - Simply Wall St

Puma Biotechnology Inc [NASDAQ: PBYI] Sees Decrease in Stock Value - Knox Daily

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - sharewise

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Financial Analysis: Puma Biotechnology Inc (PBYI)’s Ratios Unveil Key Insights - The Dwinnex

Was there any good news for Puma Biotechnology Inc (PBYI) stock in the last session? - US Post News

Q1 2026 EPS Estimates for Puma Biotechnology, Inc. Boosted by Analyst (NASDAQ:PBYI) - MarketBeat

Zacks Research Analysts Decrease Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Market Momentum: Puma Biotechnology Inc (PBYI) Registers a 4.33 Increase, Closing at 2.65 - The Dwinnex

Puma Biotech confirms court ruling on patent invalidity, disagrees with verdict - MSN

Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop - Simply Wall St

Puma Biotech patent claims partially invalidated in court - Investing.com

Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com India

Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com Australia

Puma Biotech confirms court ruling on patent dispute with AstraZeneca - Seeking Alpha

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - MSN

Post-Trade Analysis: Puma Biotechnology Inc (PBYI) Slides -24.79, Closing at 2.71 - The Dwinnex

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - Seeking Alpha

Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Michael Patrick Miller Sells 23,358 Shares of Stock - Defense World

Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Sells $81,519.42 in Stock - MarketBeat

Puma Biotechnology director sells over $81k in company stock - Investing.com

Puma Biotechnology director sells over $81k in company stock By Investing.com - Investing.com UK

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - MarketBeat

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Defense World

Vanguard Group Inc. Reduces Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Sold by Vanguard Group Inc. - MarketBeat

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye - Yahoo Finance

Puma Biotech prevails in patent suit against AstraZeneca - Investing.com

Puma Biotech prevails in patent suit against AstraZeneca - Investing.com India

Puma Biotech prevails in patent suit against AstraZeneca By Investing.com - Investing.com UK

Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - Defense World

Following a 1.5% decline over last year, recent gains may please Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional owners - Simply Wall St

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to "Strong-Buy" - MarketBeat

Citigroup upgrades Puma Biotechnology Inc (PBYI) stock to a Buy - Knox Daily

Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results - Defense World

HC Wainwright Reiterates Buy Rating for Puma Biotechnology (NASDAQ:PBYI) - Defense World

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Puma Biotechnology (NASDAQ:PBYI) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report - Yahoo Finance

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com Canada

Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com UK

Lazard Asset Management LLC Acquires 48,520 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - MSN

Puma Biotechnology (NASDAQ:PBYI) Rating Reiterated by HC Wainwright - MarketBeat

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Yahoo Finance

Analyzing Pacira BioSciences (NASDAQ:PCRX) & Puma Biotechnology (NASDAQ:PBYI) - Defense World

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Zacks Investment Research

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity - Yahoo Finance

Puma Biotech: Q2 Earnings Snapshot - San Antonio Express-News

Puma Biotech: Q2 Earnings Snapshot - Thehour.com

Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript - Seeking Alpha

Puma Biotech: Q2 Earnings Snapshot - San Francisco Chronicle

Puma Biotechnology Reports Second Quarter Financial Results - sharewise

Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Puma Biotech: Q2 Earnings Snapshot - The Washington Post

Puma Biotech: Q2 Earnings Snapshot - Santa Maria Times

Puma Biotechnology Reports Second Quarter Financial Results - Business Wire

Puma Biotechnology Inc [PBYI] President and CEO makes an insider sale of 21,920 shares worth $81128.0. - Knox Daily

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World

Puma Biotech: Q2 Earnings Snapshot - Darien Times

10,740 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by SG Americas Securities LLC - Defense World

Simile a PBYI